Pain-sparing Therapy Methods of Complicated Community Acquired Pneumonia in Children
https://doi.org/10.31550/1727-2378-2022-21-3-6-11
Abstract
Objective of the Review: to draw the attention of pediatricians and pediatric surgeons to a possibility to cut down the volume of invasive interventions in children with complicated pneumonia.
Key Points. Apart from the main task — to cure a child, an important aspect is to achieve it with as low traumatization as possible — to make its stay in hospital, as formulated by WHO, children-friendly. This task was pursued by a research in Russia that confirmed the efficacy of antibiotic-only treatment of the majority of the destructive (necrotizing) pneumonia with or without synpneumonic pleurisy. In this article we included 3 clinical cases illustrating the effectiveness of conservative therapy.
Conclusion. Immunopathological character of metapneumonic pleurisy makes it amenable to a short-course steroid therapy with a full recovery, and it renders redundant such interventions as drainage, video-assisted thoracoscopy and intrapleral fibrinolysis. Review clinical recommendations and publications of pediatric surgeons shows that they have not yet adopted pain-sparing interventions and do not compare their results to those of pediatricians who use less invasive methods.
We call on pediatric surgeons to test the sparing treatment methods proposed bi us? Cutting down on pleural punctions and limiting invasive procedures only if they are inavidable.
About the Author
V. K. Tatochenko
National Medical Research Centre of Children Health of the Ministry of Health of Russia
Russian Federation
Russian Federation
2/1, Lomonosovskiy Prosp., Moscow, 119296
References
1. Rachnsky S.V., Tatochenko V.K., eds. Pulmonnary disease in chldren. M.: Medicine; 1988. 501 p. (in Russian)
2. Geppe N.A., Kozlova L.V., Konduyrina E.G. et al. Community acquired pneumonia in children. Clinical guide. M.: Medcom-Pro; 2020. 80 p. (in Russian)
3. Bakradze M.D., Tatochenko V.K., Polyakova A.S. et al. Amoxicillin, the main drug for treating community-acquired pneumonia and otitis media, recomended but often not followed. Pediatric Pharmacology. 2016; 13(5): 425–30. (in Russian). DOI: 10.15690/pf.v13i5.1636
4. Bakradze M.D., Baranov A.A., Vishneva E.A. et al. Pneumonia (community acquired). Clinical guidelines. 2022. 74 p. (in Russian)
5. Kulichenko T.V., Baybarina E.N., Baranov A.A. et al. Pediatric health quality assessment in different regions of Russian Federation. Annals of the Russian Academy of Medical Sciences. 2016; 71(3): 214–23. (in Russian). DOI: 10.15690/vramn688
6. Tatochenko V.K. Pulmonary disease in children. A practical guide. M.: Borges; 2019. 292 p. (in Russian)
7. Barskaya M.A., Gumerov A.A., Kozlov Yu.A. et al. Acute suppurative destructive pneumonia in children. Clinical guidelines. 2018. 28 p. (in Russian)
8. Pinchuk T.P., Yasnogorodskiy O.O., Guryanova Yu.V. et al. Diagnostic and curative bronchoscopy for purulent-destructive pulmonary diseases. Pirogov Russian Journal of Surgery. 2017; 8: 33–9. (in Russian). DOI: 10.17116/hirurgia2017833-39
9. Khaspekov D.V., Olkhova E.B., Topilin V.G. et al. Modern methods of diagnostics and treatment of destructive pneumonia in children. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2015; 5(2): 7–11. (in Russian)
10. Tarakanov V.A., Barova N.K., Shumlivaya T.P. et al. Modern technology in the diagnosis and treatment of acute bacterial necrotizing pneumonia in children. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2015; 5(1): 50–6. (in Russian). DOI: 10.17816/psaic129
11. Vecherkin V.A., Toma D.A., Ptitsyn V.A. et al. Destructive pneumonia in children. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2019; 9(3): 108–15. (in Russian). DOI: 10.30946/2219-4061-2019-9-3-108-115
12. Tatochenko V.K. Community-acquired pneumonia in children — problems and solutions. Russian Bulletin of Perinatology and Pediatrics. 2021; 66(1): 9–21. (in Russian). DOI: 10.21508/1027-4065-2021-66-1-9-21
13. Long A.M., Smith-Williams J., Mayell S. et al. 'Less may be best' — pediatric parapneumonic effusion and empyema management: lessons from a UK center. J. Pediatr. Surg. 2016; 51(4): 588–91. DOI: 10.1016/j.jpedsurg.2015.07.022
14. Tagarro A., Otheo E., Baquero-Artigao F. et al. Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial. J. Pediatr. 2017; 185: 117–23.e6.
15. Botvin`eva V.V., Panasiuk N.L., Scamsiev F.M. Immunology of sin- and metapneumonic pleurisy in children. Pediatria. 1987; 10: 30–3 (in Russian)
16. Segerer F.J., Seeger K., Maier A. et al. Therapy of 645 children with parapneumonic effusion and empyema — a German nationwide surveillance study. Pediatr. Pulmonol. 2017; 52(4): 540–7. DOI: 10.1002/ppul.23562
17. Cameron R.J., Davies H.R. Intrapleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst. Rev. 2008; 2: CD002312. DOI: 10.1002/14651858.CD002312.pub3
18. Meyer Sauteur P.M., Burkhard A., Moehrlen U. et al. Pleural tap-guided antimicrobial treatment for pneumonia with parapneumonic effusion or pleural empyema in children: a single-center cohort study. J. Clin. Med. 2019; 16;8(5): 698. DOI: 10.3390/jcm8050698
Review
For citations:
Tatochenko V.K. Pain-sparing Therapy Methods of Complicated Community Acquired Pneumonia in Children. Title. 2022;21(3):6-11. (In Russ.) https://doi.org/10.31550/1727-2378-2022-21-3-6-11
Views:
18
Email this article 